HK1032915A1 - Method for modulating macrophage activation - Google Patents

Method for modulating macrophage activation

Info

Publication number
HK1032915A1
HK1032915A1 HK01103601.4A HK01103601A HK1032915A1 HK 1032915 A1 HK1032915 A1 HK 1032915A1 HK 01103601 A HK01103601 A HK 01103601A HK 1032915 A1 HK1032915 A1 HK 1032915A1
Authority
HK
Hong Kong
Prior art keywords
macrophage activation
modulating macrophage
modulating
activation
macrophage
Prior art date
Application number
HK01103601.4A
Other languages
English (en)
Inventor
Celine Morissette
Francine Gervais
Original Assignee
Bhi Ltd Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bhi Ltd Partnership filed Critical Bhi Ltd Partnership
Publication of HK1032915A1 publication Critical patent/HK1032915A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
HK01103601.4A 1998-02-11 2001-05-24 Method for modulating macrophage activation HK1032915A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7429598P 1998-02-11 1998-02-11
US24839699A 1999-02-10 1999-02-10
PCT/IB1999/000354 WO1999040909A1 (en) 1998-02-11 1999-02-11 Method for modulating macrophage activation

Publications (1)

Publication Number Publication Date
HK1032915A1 true HK1032915A1 (en) 2001-08-10

Family

ID=26755484

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103601.4A HK1032915A1 (en) 1998-02-11 2001-05-24 Method for modulating macrophage activation

Country Status (13)

Country Link
EP (1) EP1054664B1 (xx)
JP (1) JP4574845B2 (xx)
AU (1) AU2437899A (xx)
CA (2) CA2632106A1 (xx)
CY (1) CY1113205T1 (xx)
DK (1) DK1054664T3 (xx)
ES (1) ES2392391T3 (xx)
HK (1) HK1032915A1 (xx)
IL (1) IL137751A0 (xx)
MX (2) MXPA00007815A (xx)
NZ (2) NZ550199A (xx)
PT (1) PT1054664E (xx)
WO (1) WO1999040909A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CA2333203A1 (en) * 1998-05-15 1999-11-25 Neurochem Inc. Methods for modulating neuronal cell death
US6310073B1 (en) 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
CA2369997C (en) * 1999-04-28 2009-11-17 Queen's University At Kingston Compositions and methods for treating amyloidosis
CA2375628A1 (en) * 1999-07-09 2001-01-18 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
EP1251837A2 (en) 1999-12-23 2002-10-30 Neurochem, Inc. Compounds and methods for modulating cerebral amyloid angiopathy
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20060135403A1 (en) * 2002-12-24 2006-06-22 Francine Gervais Therapeutic formulations for the treatment of beta-amyloid related diseases
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
JP2007516940A (ja) * 2003-06-23 2007-06-28 ニューロケム （インターナショナル） リミテッド 改善された薬剤候補およびその調製法
US7253306B2 (en) 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
US20050142191A1 (en) 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
PT1954718E (pt) 2005-11-30 2014-12-16 Abbvie Inc Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
DK2089417T3 (en) 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
AU2008311367B2 (en) 2007-10-05 2014-11-13 Ac Immune S.A. Use of anti-amyloid beta antibody in ocular diseases
WO2010094734A2 (en) * 2009-02-19 2010-08-26 Biofocus Dpi B.V. Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
AR078290A1 (es) * 2009-09-17 2011-10-26 North Texas Medical Ass Composicion farmaceutica. funcion del acido n-2-hidroxi-etil-piperazin-n`-2- etanosulfonico (hepes) en el control del dolor y en la prevencion de lesiones desmielinizantes. metodo para tratar dolor.
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
CN103179981B (zh) 2010-07-30 2017-02-08 Ac免疫有限公司 安全和功能性的人源化抗β‑淀粉样蛋白抗体
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins
WO2016163886A2 (en) * 2015-04-10 2016-10-13 Clues2Cure International B.V. Administration of taurine or an analog thereof for the treatment of nerve cell damage
CN109381452A (zh) * 2017-08-11 2019-02-26 江西青峰药业有限公司 乙基硫酸类化合物的应用及其制备方法
CN109381453A (zh) * 2017-08-14 2019-02-26 江西青峰药业有限公司 乙基硫酸钾在制备用于预防或治疗炎症性疾病药物中的应用
CN109394746A (zh) * 2017-08-15 2019-03-01 江西青峰药业有限公司 乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用
WO2023212289A1 (en) 2022-04-28 2023-11-02 Alzheon, Inc. Tramiprosate for treating apoe4-related diseases
WO2024119183A1 (en) 2022-12-02 2024-06-06 Alzheon, Inc. Methods for treating neurodegenerative disorders with tramiprosate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
US5087618A (en) * 1982-05-18 1992-02-11 University Of Florida Redox carriers for brain-specific drug delivery
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5276059A (en) * 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
CA2159326C (en) * 1993-03-29 2000-05-30 Robert Kisilevsky Method for treating amyloidosis
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
CA2300910C (en) * 1997-08-18 2008-02-26 Queen's University At Kingston Phosphono-carboxylate compounds for treating amyloidosis
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis

Also Published As

Publication number Publication date
NZ568553A (en) 2010-02-26
IL137751A0 (en) 2001-10-31
MX2008014823A (es) 2009-03-06
CA2320224C (en) 2008-08-12
MXPA00007815A (es) 2002-04-24
JP2002502871A (ja) 2002-01-29
NZ550199A (en) 2008-07-31
DK1054664T3 (da) 2012-11-05
ES2392391T3 (es) 2012-12-10
JP4574845B2 (ja) 2010-11-04
EP1054664A1 (en) 2000-11-29
CA2632106A1 (en) 1999-08-19
WO1999040909A1 (en) 1999-08-19
EP1054664B1 (en) 2012-08-08
AU2437899A (en) 1999-08-30
CA2320224A1 (en) 1999-08-19
PT1054664E (pt) 2012-11-02
CY1113205T1 (el) 2016-04-13

Similar Documents

Publication Publication Date Title
IL137751A0 (en) Method for modulating macrophage activation
AU3822399A (en) Device for treating aneurysms
GB9809414D0 (en) Method
AU1177400A (en) Apparatus for photoreaction
AU137780S (en) An applicator
GB9814055D0 (en) Method
GB9810722D0 (en) Method
GB9819769D0 (en) Method
GB9802475D0 (en) Method
GB9817266D0 (en) Method
GB9824321D0 (en) Method
AU2002301959A1 (en) Method for modulating macrophage activation
GB9820185D0 (en) Method
GB9821225D0 (en) Method
GB9826574D0 (en) Control method
GB9809780D0 (en) Method
GB9821038D0 (en) Method
GB9809782D0 (en) Method
GB9804070D0 (en) Control apparatus
GB9825484D0 (en) Control method
GB9823963D0 (en) Method
GB9825374D0 (en) Method
GB9825032D0 (en) Method
GB9820847D0 (en) Method
GB9820529D0 (en) Method

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190210